Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
33.96
+2.10 (6.59%)
At close: Jan 30, 2025, 4:00 PM
34.17
+0.21 (0.62%)
Pre-market: Jan 31, 2025, 4:55 AM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 26.21, with a low estimate of 11 and a high estimate of 42. The average target predicts a decrease of -22.82% from the current stock price of 33.96.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HIMS stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 6 | 6 | 6 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 12 | 12 | 12 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold → Strong Sell Downgrades $24 → $25 | Hold → Strong Sell | Downgrades | $24 → $25 | -26.38% | Jan 10, 2025 |
| BTIG | BTIG | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +3.06% | Jan 7, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | -29.33% | Jan 6, 2025 |
| Needham | Needham | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | -8.72% | Jan 6, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $42 | Buy | Initiates | $42 | +23.67% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
1.50B
from 872.00M
Increased by 71.44%
Revenue Next Year
2.10B
from 1.50B
Increased by 40.33%
EPS This Year
0.56
from -0.11
EPS Next Year
0.55
from 0.56
Decreased by -1.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.5B | 2.4B | 3.0B | |||
| Avg | 1.5B | 2.1B | 2.4B | |||
| Low | 1.4B | 1.6B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 77.6% | 57.4% | 41.1% | |||
| Avg | 71.4% | 40.3% | 15.3% | |||
| Low | 64.3% | 10.3% | -10.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.66 | 0.94 | 1.08 | |||
| Avg | 0.56 | 0.55 | 0.73 | |||
| Low | 0.49 | 0.18 | 0.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 67.7% | 96.8% | |||
| Avg | - | -1.6% | 31.9% | |||
| Low | - | -68.4% | -35.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.